Who owns iShares U.S. Pharmaceuticals ETF?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of IHE from SEC Form 13F filings across 249 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 249 institutions disclosed 11.4M shares of iShares U.S. Pharmaceuticals ETF worth $1.14B — about 100.8% of shares outstanding; the largest disclosed holder is Fisher Asset Management, LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
249
13F holders
$1.14B
value, 2026 filers
100.8%
of shares outstanding (11.4M sh)
64
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of IHE's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Fisher Asset Management, LLC | 2.7M | $271.8M | 0.1% | 23.9% | -1.0% |
| 2 | Foundations Investment Advisors, LLC | 982,196 | $98.7M | 1.0% | 8.7% | +24278.2% |
| 3 | MORGAN STANLEY | 882,272 | $88.7M | 0.0% | 7.8% | +92.8% |
| 4 | BANK OF AMERICA CORP /DE/ | 578,702 | $58.2M | 0.0% | 5.1% | -32.9% |
| 5 | JPMORGAN CHASE & CO | 430,242 | $44.0M | 0.0% | 3.8% | -22.3% |
| 6 | MML INVESTORS SERVICES, LLC | 418,061 | $42.0M | 0.1% | 3.7% | +4438.7% |
| 7 | TD ASSET MANAGEMENT INC | 320,547 | $32.8M | 0.0% | 2.8% | +66.5% |
| 8 | MinichMacGregor Wealth Management, LLCNEW | 319,306 | $32.1M | 5.2% | 2.8% | new |
| 9 | LPL Financial LLC | 311,911 | $31.4M | 0.0% | 2.8% | +35.1% |
| 10 | Horizon Investments, LLCNEW | 305,190 | $30.7M | 0.3% | 2.7% | new |
| 11 | BANK OF MONTREAL /CAN/ | 282,799 | $28.4M | 0.0% | 2.5% | +3516.4% |
| 12 | Aptus Capital Advisors, LLCNEW | 277,207 | $27.9M | 0.2% | 2.4% | new |
| 13 | EXCHANGE TRADED CONCEPTS, LLCNEW | 252,840 | $25.4M | 0.1% | 2.2% | new |
| 14 | WELLS FARGO & COMPANY/MN | 245,677 | $24.7M | 0.0% | 2.2% | +225.6% |
| 15 | ROYAL BANK OF CANADA | 211,266 | $21.2M | 0.0% | 1.9% | +56.3% |
| 16 | UBS Group AG | 182,922 | $18.4M | 0.0% | 1.6% | +66.1% |
| 17 | GOLDMAN SACHS GROUP INC | 167,603 | $16.8M | 0.0% | 1.5% | -9.8% |
| 18 | McElhenny Sheffield Capital Management, LLCNEW | 131,327 | $13.2M | 3.1% | 1.2% | new |
| 19 | Prospera Financial Services IncNEW | 130,953 | $14.1M | 0.2% | 1.2% | new |
| 20 | OSAIC HOLDINGS, INC. | 119,041 | $12.0M | 0.0% | 1.1% | +1130.7% |
| 21 | RAYMOND JAMES FINANCIAL INC | 104,470 | $10.5M | 0.0% | 0.9% | +45.4% |
| 22 | AMERIPRISE FINANCIAL INC | 83,785 | $8.4M | 0.0% | 0.7% | +100.8% |
| 23 | ARKANSAS FINANCIAL GROUP, INC. | 76,892 | $7.7M | 1.0% | 0.7% | +227.4% |
| 24 | Well Done, LLCNEW | 75,448 | $7.6M | 1.0% | 0.7% | new |
| 25 | BROWN ADVISORY INC | 75,432 | $7.6M | 0.0% | 0.7% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation. Research, not investment advice.